SE8404929L - Antibiotiskt antitumorkomplex - Google Patents

Antibiotiskt antitumorkomplex

Info

Publication number
SE8404929L
SE8404929L SE8404929A SE8404929A SE8404929L SE 8404929 L SE8404929 L SE 8404929L SE 8404929 A SE8404929 A SE 8404929A SE 8404929 A SE8404929 A SE 8404929A SE 8404929 L SE8404929 L SE 8404929L
Authority
SE
Sweden
Prior art keywords
bbm
complex
antibiotic antitumor
antitumor complex
antibacterial
Prior art date
Application number
SE8404929A
Other languages
English (en)
Other versions
SE8404929D0 (sv
SE460481B (sv
Inventor
M Konishi
K Sugawara
T Miyaki
H Kawaguchi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8404929D0 publication Critical patent/SE8404929D0/sv
Publication of SE8404929L publication Critical patent/SE8404929L/sv
Publication of SE460481B publication Critical patent/SE460481B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8404929A 1983-10-03 1984-10-02 Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning SE460481B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,453 US4518589A (en) 1983-10-03 1983-10-03 BBM-2478 Antibiotic complex

Publications (3)

Publication Number Publication Date
SE8404929D0 SE8404929D0 (sv) 1984-10-02
SE8404929L true SE8404929L (sv) 1985-04-04
SE460481B SE460481B (sv) 1989-10-16

Family

ID=24146999

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404929A SE460481B (sv) 1983-10-03 1984-10-02 Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning

Country Status (29)

Country Link
US (1) US4518589A (sv)
JP (2) JPS60115599A (sv)
AT (1) AT381507B (sv)
AU (1) AU570271B2 (sv)
BE (1) BE900735A (sv)
CA (1) CA1242159A (sv)
CH (1) CH666043A5 (sv)
CY (1) CY1534A (sv)
DE (1) DE3436137C2 (sv)
DK (1) DK473484A (sv)
ES (1) ES536455A0 (sv)
FI (1) FI79141C (sv)
FR (1) FR2555586B1 (sv)
GB (1) GB2147582B (sv)
GR (1) GR80551B (sv)
HK (1) HK82790A (sv)
HU (1) HU192461B (sv)
IE (1) IE57825B1 (sv)
IL (1) IL73126A (sv)
IT (1) IT1176854B (sv)
LU (1) LU85572A1 (sv)
MX (1) MX9202848A (sv)
MY (1) MY101664A (sv)
NL (1) NL8403002A (sv)
OA (1) OA07827A (sv)
PT (1) PT79310B (sv)
SE (1) SE460481B (sv)
SU (1) SU1423001A3 (sv)
ZA (1) ZA847723B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859598A (en) * 1984-03-26 1989-08-22 American Cyanamid Company Antibiotic LL-D42067β
US4626503A (en) * 1984-04-04 1986-12-02 American Cyanamid Company Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3
NZ211872A (en) * 1984-04-27 1989-06-28 Ishihara Sangyo Kaisha Chartreusin derivatives and antitumorous compositions
EP0219852B1 (en) * 1985-10-23 1992-02-05 Ishihara Sangyo Kaisha, Ltd. Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same
ATE112284T1 (de) * 1989-01-30 1994-10-15 Ishihara Sangyo Kaisha Exo-3'-4'-o-benzyliden-3''-demethylchartreusin und seine salze.
IN172911B (sv) * 1991-02-26 1994-01-01 Hoechst India
HU210418B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for prepg. 2"-n-acyl derivs of elsamycin a and pharmaceutical compositions containing them
US5229371A (en) * 1991-05-30 1993-07-20 Bristol-Myers Squibb Company Chemical modification of elsamicin A at the 3' and/or 4' OH groups
HU210492B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for preparing novel 6-0-acyl deriv.s of elsamicin a and pharmaceutical copn.s contg. them
HU210499B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for preparing 6-o-alkylelsamicin a deriv.s and pharmaceutical compn.s contg. them
US5237055A (en) * 1991-05-30 1993-08-17 Bristol-Myers Squibb Company Chemical modification of 2"-amino group in elsamicin A
HU210162B (en) * 1991-05-30 1995-02-28 Bristol Myers Squibb Co Process for preparing 3',4'-o-substituted elsamicin a deriv.s and pharmaceutical compn.s contg. them
US5508268A (en) * 1993-08-12 1996-04-16 Bristol-Myers Squibb Parenteral elsamitrucin formulations
WO2008092103A2 (en) * 2007-01-25 2008-07-31 Spectrum Pharmaceuticals, Inc. Combination cancer treatments comprising elsamitrucin and other agents
MX2008015971A (es) * 2007-05-24 2009-01-12 Spectrum Pharmaceuticals Inc Sales de elsamitrucina estables adecuadas para formulaciones farmaceuticas.
BRPI0820811A2 (pt) * 2007-12-19 2018-03-27 Spectrum Pharmaceuticals Inc formulação de sal estável de elsamitrucina
JP2009207970A (ja) * 2008-03-03 2009-09-17 Marsima Aqua System Corp 空気揚水装置
CN111751469B (zh) * 2020-07-06 2022-06-14 江苏省中医院 一种液相色谱串联质谱测定血浆中教酒菌素浓度的方法

Also Published As

Publication number Publication date
FI843823L (fi) 1985-04-04
ATA313184A (de) 1986-03-15
SE8404929D0 (sv) 1984-10-02
CY1534A (en) 1990-11-16
DE3436137A1 (de) 1985-05-15
IL73126A (en) 1989-05-15
CA1242159A (en) 1988-09-20
ES8602135A1 (es) 1985-11-16
BE900735A (fr) 1985-04-02
DK473484A (da) 1985-04-04
MY101664A (en) 1991-12-31
HK82790A (en) 1990-10-19
CH666043A5 (de) 1988-06-30
DE3436137C2 (de) 1993-12-02
PT79310A (en) 1984-11-01
US4518589A (en) 1985-05-21
JPH0641182A (ja) 1994-02-15
IE57825B1 (en) 1993-04-21
OA07827A (fr) 1986-11-20
GB2147582A (en) 1985-05-15
GR80551B (en) 1985-02-06
GB2147582B (en) 1987-04-15
FR2555586A1 (fr) 1985-05-31
SE460481B (sv) 1989-10-16
FR2555586B1 (fr) 1988-10-07
GB8424810D0 (en) 1984-11-07
AT381507B (de) 1986-10-27
ZA847723B (en) 1985-05-29
MX9202848A (es) 1992-06-30
LU85572A1 (fr) 1985-06-19
ES536455A0 (es) 1985-11-16
JPS60115599A (ja) 1985-06-22
HU192461B (en) 1987-06-29
DK473484D0 (da) 1984-10-02
FI79141C (sv) 1989-11-10
IT8422961A0 (it) 1984-10-03
IL73126A0 (en) 1984-12-31
AU3354884A (en) 1986-09-11
AU570271B2 (en) 1988-03-10
HUT37170A (en) 1985-11-28
IT1176854B (it) 1987-08-18
FI843823A0 (fi) 1984-09-28
IT8422961A1 (it) 1986-04-03
JPH0689017B2 (ja) 1994-11-09
FI79141B (fi) 1989-07-31
NL8403002A (nl) 1985-05-01
JPH0566394B2 (sv) 1993-09-21
IE842511L (en) 1985-04-03
PT79310B (en) 1986-11-14
SU1423001A3 (ru) 1988-09-07

Similar Documents

Publication Publication Date Title
SE8404929D0 (sv) Bbm-2478 antibiotic complex
GB8409877D0 (en) Capacitance effect keyboard
AU6658181A (en) Increasing antibiotic action of antibiotics
AU1617688A (en) Shielding panel
EP0126313A3 (en) Use of diterpene derivatives of forskolin for immune stimulation
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
GT196000041A (es) Antibioticos a-21978 y procedimiento para su produccion
AU6344380A (en) Lincomycin and clindamycin analogues
AU523222B2 (en) Antibiotic produced from bacillus laterosporus culture
ES474327A1 (es) Un procedimiento para producir el complejo antibiotico de desoxinarasina
IT7831423A0 (it) Antibiotico prodotto da microorganismi del genere pseudomonas e procedimento per la sua produzione
SE7706350L (sv) Antitumor -antibiotika
SE8402619D0 (sv) Bbm-1675, a new antitumor antibiotic complex
AU637672B2 (en) Process of producing linear alpha-olefins
IE781566L (en) Antitumour anthracycline antibiotics
EP0255299A3 (en) Glycopeptide antibiotics
AU5581880A (en) Furniture assemblies
AU5576680A (en) Assembly of furniture
AU591290B2 (en) Rapid detection of n. gonorrhoeae without culture
YU46576B (sh) Postupak za dobijanje etarskog policikličnog antibiotika
NZ184142A (en) Antibiotics of a-35512 group from culturing streptomyces candidus nrrl 8156
ES472790A1 (es) Un procedimiento para obtener un nuevo antibiotico antitumo-ral la auromomicina
AU6902987A (en) An article of furniture
AU5048585A (en) An article of furniture
EP0376609A3 (en) Antibiotic a80915 and process for its production

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404929-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404929-5

Format of ref document f/p: F